Early stage funding Seed funding of 1.6M plus NSF grant indicates validated interest and potential for rapid expansion; opportunity to position Transparent Path as a scalable, ROI-driven partner for multinational pharma and food brands expanding in new regions.

Global expansion Recent market entry into the Southern Hemisphere and participation in international expos suggests openness to new geographic customers; sales approach can target cross-border supply chain partners and regional manufacturers needing real-time visibility.

Perishables focus Specialization in perishables with IoT, AI, and collaborative cloud signals a fit for cold chain players, processors, and retailers seeking risk reduction and cost efficiency; pitch to cold chain logistics providers and pharmaceutical distributors.

Secured partnerships Signing a pivotal partnership with Sidera Consult signals credibility; leverage this and similar alliances to access enterprise leads in pharma, food, and logistics networks prioritizing supply chain resilience.

Technological edge Utilization of IoT sensors, OpenAI, and real-time analytics positions the company to sell as a sophisticated, future-ready platform; demonstrate measurable reductions in spoilage, delays, and environmental impact to potential customers and investors.